|
127 Companies |
|
139 Products |
|
139 Products |
|
89 Mechanisms of Action |
|
9 Trials |
|
1220 News |
|
| «12...1213141516171819202122...2425» |
- | New P4 trial: The Effect of Nutritional Counseling for Cancer Patients (clinicaltrials.gov) - Oct 10, 2013
P4, N=61, Completed, Sponsor: University of Copenhagen
- Trial completion: The Effect of Nutritional Counseling for Cancer Patients (clinicaltrials.gov) - Oct 10, 2013
P4, N=61, Completed, Sponsor: University of Copenhagen
Not yet recruiting --> Completed
- ||| relamorelin (RM-131) / AbbVie
Enrollment change: Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis (clinicaltrials.gov) - Oct 9, 2013
P2, N=185, Active, not recruiting, Sponsor: Rhythm Pharmaceuticals, Inc.
Not yet recruiting --> Completed N=125 --> 185
- triamcinolone acetonide / Generic mfg.
Clinical: The Efficacy of Topical Bupivacaine and Triamcinolone Acetonide Injection in the Relief of Pain After Endoscopic Submucosal Dissection for Gastric Neoplasia: A Randomized Double-blind, Placebo-controlled Trial (clinicaltrials.gov) - Oct 9, 2013
P=N/A, N=111, Completed, Sponsor: Yonsei University
- ||| relamorelin (RM-131) / AbbVie
Enrollment closed: Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis (clinicaltrials.gov) - Oct 9, 2013
P2, N=185, Active, not recruiting, Sponsor: Rhythm Pharmaceuticals, Inc.
N=125 --> 185 Recruiting --> Active, not recruiting
- | cabazitaxel / Generic mfg.
New P2 trial, Metastases: Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer (clinicaltrials.gov) - Oct 6, 2013
P2, N=65, Recruiting, Sponsor: Krankenhaus Nordwest
- Surgery, Metastases: FTSlapAG: Fast Track Surgery With Laparoscopic-assisted Gastrectomy for Advanced Gastric Cancer: a Randomized Controlled Trial (clinicaltrials.gov) - Oct 4, 2013
P=N/A, N=61, Completed, Sponsor: Quan Wang
- pemetrexed / Generic mfg.
New P2 trial, Metastases: Phase II Study of Pemetrexed in Advanced or Recurrent Gastric Cancer After Chemotherapy (clinicaltrials.gov) - Sep 29, 2013
P2, N=40, Recruiting, Sponsor: Sun Yat-sen University
- esomeprazole / Generic mfg.
Enrollment change: The Efficacy of Double Doses of Oral Esomeprazole in Preventing Rebleeding for Patients With Bleeding Peptic Ulcers (clinicaltrials.gov) - Sep 28, 2013
P4, N=300, Recruiting, Sponsor: National Cheng-Kung University Hospital
Recruiting --> Active, not recruiting N=200 --> 300
- MK-2206 / Merck (MSD), Herceptin (trastuzumab) / Roche
Trial termination: Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery (clinicaltrials.gov) - Sep 26, 2013
P1, N=60, Terminated, Sponsor: National Cancer Institute (NCI)
N=200 --> 300 Recruiting --> Terminated
- epinephrine / Generic mfg.
Trial completion: Comparative Study of Autologous Blood Injection Versus Diluted Epinephrine in Treating Actively Bleeding Gastroduodenal Ulcers (clinicaltrials.gov) - Sep 23, 2013
P=N/A, N=100, Completed, Sponsor: Zagazig University
Recruiting --> Terminated Recruiting --> Completed
- 5-fluorouracil / Generic mfg., oxaliplatin / Generic mfg., epirubicin / Generic mfg.
Enrollment change, Metastases: Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC (clinicaltrials.gov) - Sep 20, 2013
P2, N=163, Completed, Sponsor: Fudan University
Recruiting --> Completed N=80 --> 163
- 5-fluorouracil / Generic mfg., oxaliplatin / Generic mfg., epirubicin / Generic mfg.
Trial completion, Metastases: Continuous Infusion of FU Combined With Epirubicin and Oxaliplatin in Patients With A/MGC (clinicaltrials.gov) - Sep 20, 2013
P2, N=163, Completed, Sponsor: Fudan University
N=80 --> 163 Recruiting --> Completed
- | Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka
New P2 trial, Metastases: A Phase II Trial of Adjuvant Chemotherapy With S-1 Plus Oxaliplatin for Locally Advanced Gastric Cancer (clinicaltrials.gov) - Sep 17, 2013
P2, N=54, Recruiting, Sponsor: Yonsei University
- Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka
Enrollment change, Combination therapy, Metastases: A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer (clinicaltrials.gov) - Sep 16, 2013
P1, N=27, Completed, Sponsor: Chinese Academy of Medical Sciences
Recruiting --> Completed N=20 --> 27
- Clinical: RCT: WLE vs. NBI in Upper Gastrointestinal Endoscopy (clinicaltrials.gov) - Sep 16, 2013
P=N/A, N=464, Recruiting, Sponsor: Changi General Hospital
- Teysuno (gimeracil/oteracil/tegafur) / Nordic Group, Otsuka
Trial completion, Combination therapy, Metastases: A Phase I Study of S-1 in Combination With Radiotherapy in Locally Advanced or Recurrent Gastric Cancer (clinicaltrials.gov) - Sep 16, 2013
P1, N=27, Completed, Sponsor: Chinese Academy of Medical Sciences
N=20 --> 27 Recruiting --> Completed
- Trial completion: Water-jet Assisted ESD vs Conventional ESD Technique for Treating Early Gastric Cancer (clinicaltrials.gov) - Sep 10, 2013
P=N/A, N=117, Completed, Sponsor: Shanghai Zhongshan Hospital
Recruiting --> Completed Not yet recruiting --> Completed
- | New P2 trial, Surgery: Early Recovery After Surgery (ERAS) Versus Conventional Protocol After Laparoscopic Gastrectomy (clinicaltrials.gov) - Sep 8, 2013
P2, N=100, Recruiting, Sponsor: Seoul National University Bundang Hospital
- Trial termination: Perioperative Nutrition in Upper Gastrointestinal (GI) Cancer Surgery (clinicaltrials.gov) - Sep 3, 2013
P=N/A, N=43, Terminated, Sponsor: Dan Azagury
Not yet recruiting --> Completed Recruiting --> Terminated; Insufficient recruitment over time.
- Enrollment change: Perioperative Nutrition in Upper Gastrointestinal (GI) Cancer Surgery (clinicaltrials.gov) - Sep 3, 2013
P=N/A, N=43, Terminated, Sponsor: Dan Azagury
Recruiting --> Terminated; Insufficient recruitment over time. N=95 --> 43
- ||| Enrollment open, Surgery: Postoperative Oral Nutritional Supplementation After Major Gastrointestinal Surgery (clinicaltrials.gov) - Sep 3, 2013
P=N/A, N=174, Recruiting, Sponsor: Seoul National University Hospital
N=95 --> 43 Not yet recruiting --> Recruiting
- ||||| camicinal (GSK962040) / GSK
New P2 trial: Nutritional Adequacy Therapeutic Enhancement in the Critically Ill. The NUTRIATE Study (clinicaltrials.gov) - Sep 2, 2013
P2, N=150, Recruiting, Sponsor: GlaxoSmithKline
- epinephrine / Generic mfg.
Enrollment change: Comparative Study of Autologous Blood Injection Versus Diluted Epinephrine in Treating Actively Bleeding Gastroduodenal Ulcers (clinicaltrials.gov) - Sep 1, 2013
P=N/A, N=100, Completed, Sponsor: Zagazig University
Not yet recruiting --> Recruiting N=50 --> 100
- | emibetuzumab (LY2875358) / Eli Lilly, Innovent Biologics
Enrollment open, Metastases: A Study of LY2875358 in Participants With MET Positive, Advanced Gastric Cancer (clinicaltrials.gov) - Aug 26, 2013
P2, N=15, Recruiting, Sponsor: Eli Lilly and Company
N=50 --> 100 Not yet recruiting --> Recruiting
- ||| ASG 5ME / Pfizer
Trial completion: A Phase 1 Dose Escalation Trial of ASG-5ME in Pancreatic or Gastric Adenocarcinoma (clinicaltrials.gov) - Aug 22, 2013
P1, N=51, Completed, Sponsor: Seattle Genetics, Inc.
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- p53MVA - Tara I / O
Enrollment change: Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer (clinicaltrials.gov) - Aug 20, 2013
P1, N=12, Completed, Sponsor: City of Hope Medical Center
Active, not recruiting --> Completed N=15 --> 12
- p53MVA - Tara I / O
Trial completion: Vaccine Therapy in Treating Patients With Colorectal, Stomach, or Pancreatic Cancer (clinicaltrials.gov) - Aug 20, 2013
P1, N=12, Completed, Sponsor: City of Hope Medical Center
N=15 --> 12 Suspended --> Completed
- Trial completion, Metastases: Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer (clinicaltrials.gov) - Aug 18, 2013
P2, N=40, Completed, Sponsor: National Taiwan University Hospital
Suspended --> Completed Active, not recruiting --> Completed
- Enrollment change: Long-term Follow-up Prognosis of Atrophic Gastritis After 3 Years (clinicaltrials.gov) - Aug 14, 2013
P=N/A, N=3328, Completed, Sponsor: Konkuk University Medical Center
Active, not recruiting --> Completed N=2500 --> 3328
- Trial completion: Long-term Follow-up Prognosis of Atrophic Gastritis After 3 Years (clinicaltrials.gov) - Aug 14, 2013
P=N/A, N=3328, Completed, Sponsor: Konkuk University Medical Center
N=2500 --> 3328 Recruiting --> Completed
- Enrollment change, HEOR: Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Health-Related Quality of Life in Patients Undergoing Total Gastrectomy for Adenocarcinoma (clinicaltrials.gov) - Aug 13, 2013
P3, N=12, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
Recruiting --> Completed N=40 --> 12
- Trial completion, HEOR: Impact of Roux-En-Y Pouch Reconstruction Compared With Conventional Roux-En-Y Reconstruction on Health-Related Quality of Life in Patients Undergoing Total Gastrectomy for Adenocarcinoma (clinicaltrials.gov) - Aug 13, 2013
P3, N=12, Completed, Sponsor: Memorial Sloan-Kettering Cancer Center
N=40 --> 12 Recruiting --> Completed
- | dovitinib (TKI258) / Novartis, Oncoheroes
New P1/2 trial, Metastases: Dovitinib Plus Docetaxel in Gastric Cancer (clinicaltrials.gov) - Aug 11, 2013
P1/2, N=59, Recruiting, Sponsor: Asan Medical Center
- remifentanil / Generic mfg., dexmedetomidine / Generic mfg.
Clinical: A Comparison of Efficacy and Safety During Endoscopic Submucosal Dissection Between Dexmedetomidine-remifentanil and Propofol-remifentanil (clinicaltrials.gov) - Aug 7, 2013
P=N/A, N=60, Active, not recruiting, Sponsor: Yonsei University
- Enrollment open: Postoperative Morbidity and Mortality After Gastrectomy for Gastric Cancer: Prospective Cohort Study (clinicaltrials.gov) - Aug 6, 2013
P=N/A, N=2000, Recruiting, Sponsor: Yonsei University
Recruiting --> Completed Not yet recruiting --> Recruiting
- | docetaxel / Generic mfg.
Trial completion: CRUK/07/013: Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer (clinicaltrials.gov) - Aug 5, 2013
P3, N=320, Completed, Sponsor: Cambridge University Hospitals NHS Foundation Trust
Not yet recruiting --> Recruiting Recruiting --> Completed
- 5-fluorouracil / Generic mfg., cisplatin / Generic mfg.
Trial completion: Endoscopic Ultrasound in Diagnosing Cancer in Patients With Localized Stomach Cancer or Esophageal Cancer (clinicaltrials.gov) - Aug 5, 2013
P=N/A, N=700, Completed, Sponsor: North Wales Organisation for Randomised Trials in Health
Recruiting --> Completed Active, not recruiting --> Completed
- Chantix (varenicline) / Pfizer
Enrollment change: Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking (clinicaltrials.gov) - Aug 4, 2013
P=N/A, N=315, Completed, Sponsor: Butler Hospital
Active, not recruiting --> Completed N=602 --> 315
- Chantix (varenicline) / Pfizer
Trial completion: Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking (clinicaltrials.gov) - Aug 4, 2013
P=N/A, N=315, Completed, Sponsor: Butler Hospital
N=602 --> 315 Active, not recruiting --> Completed
- Trial withdrawal, Metastases: Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer (clinicaltrials.gov) - Aug 1, 2013
P1, N=0, Withdrawn, Sponsor: University of Alabama at Birmingham
Active, not recruiting --> Completed Active, not recruiting --> Withdrawn
- ||| fexagratinib (ABSK091) / Abbisko
Enrollment closed, Monotherapy, Metastases: SHINE: Efficacy and Safety of AZD4547 Versus Paclitaxel in Patients With Advanced Gastric or Gastro-oesophageal Cancer (clinicaltrials.gov) - Aug 1, 2013
P2, N=960, Active, not recruiting, Sponsor: AstraZeneca
Active, not recruiting --> Withdrawn Recruiting --> Active, not recruiting
- New P4 trial, Metastases: Application of Somatostatin for Advanced Gastric Cancer After D2 Lymph Node Dissection (clinicaltrials.gov) - Jul 31, 2013
P4, N=2, Completed, Sponsor: First Affiliated Hospital, Sun Yat-Sen University
- clarithromycin / Generic mfg.
Enrollment change: Clarithromycin Resistant Tailored Therapy (clinicaltrials.gov) - Jul 30, 2013
P4, N=924, Completed, Sponsor: Jin Il Kim
Recruiting --> Active, not recruiting N=1232 --> 924
- clarithromycin / Generic mfg.
Trial completion: Clarithromycin Resistant Tailored Therapy (clinicaltrials.gov) - Jul 30, 2013
P4, N=924, Completed, Sponsor: Jin Il Kim
N=1232 --> 924 Recruiting --> Completed
- ||| Vectibix (panitumumab) / Amgen
Enrollment closed: NEOPECX: ECX + Panitumumab vs. ECX Alone in Locally Advanced Gastric Cancer or Cancer of the Gastroesophageal Junction (clinicaltrials.gov) - Jul 29, 2013
P2, N=171, Active, not recruiting, Sponsor: AIO-Studien-gGmbH
Recruiting --> Completed Recruiting --> Active, not recruiting
- |||| rilotumumab (AMG 102) / Amgen
Trial completion, Metastases: AMG 102 Plus ECX for Unresectable Locally Advanced or Metastatic Gastric or Esophagogastric Junction Cancer (clinicaltrials.gov) - Jul 29, 2013
P1/2, N=130, Completed, Sponsor: Amgen
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- Enrollment change: Early Selective TAE to Severely Bleeding Peptic Ulcers After Their Initial Endoscopic Hemostasis (clinicaltrials.gov) - Jul 28, 2013
P4, N=250, Recruiting, Sponsor: Chinese University of Hong Kong
Active, not recruiting --> Completed N=194 --> 250
- | lansoprazole / Generic mfg.
Trial completion: Effect of Prevacid on Prostaglandin Levels in Patient With Stress Ulcer (clinicaltrials.gov) - Jul 28, 2013
P4, N=30, Completed, Sponsor: Emory University
N=194 --> 250 Recruiting --> Completed
- oxaliplatin / Generic mfg., leucovorin calcium / Generic mfg., everolimus / Generic mfg.
Enrollment change, Metastases: Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer (clinicaltrials.gov) - Jul 23, 2013
P1/2, N=44, Active, not recruiting, Sponsor: City of Hope Medical Center
Recruiting --> Completed N=26 --> 44